单中心维持性血透患者钙磷代谢情况及用药依从性分析
Analysis of Calcium and Phosphorus Metabolism and Medication Compliance in Patients with Single-Center Maintenance Hemodialysis
DOI: 10.12677/ACM.2019.99171, PDF,    国家自然科学基金支持
作者: 余 莹, 张晓琴, 张 昆, 黄洁丽, 李江涛, 余 晨:同济大学附属同济医院肾内科,上海
关键词: 维持性血液透析血磷血钙iPTH依从性Maintenance Hemodialysis Blood Phosphorus Blood Calcium iPTH Compliance
摘要: 目的:探讨分析单中心维持性血液透析患者钙磷代谢情况,以及钙磷调节药物的用药情况。方法:选取2018年1月在同济大学附属同济医院医院血液净化中心行规律血液透析3个月以上的维持性血液透析患者为研究分析对象,回顾性分析患者透析前血磷、血钙、血白蛋白和全段甲状旁腺激素(iPTH)指标,分析钙、磷及iPTH达标情况,收集患者钙磷调节药物的用药情况,统计患者性别、年龄、透析龄、透析频率、磷结合剂、活性维生素D、钙剂等使用状况并进行统计学分析。结果:1) 患者平均校正血钙值为(2.25 ± 0.19) mmol/L,校正总钙低于目标标准共23例,占比为14.29%,达标者共131例占比为81.37%,7例患者高于标准值,占比为5.34%;平均血磷值为(1.68 ± 0.51) mmol/L,1例血磷指数比目标标准低,占比为0.61%,共52例达标,占比为32.29%,108例高于标准值,占比为67.08%;平均iPTH值为(341.65 ± 351.81) pg/ml,1例比目标标准低,占比为0.61%,共22例达标,占比为13.67,138例高于标准值占比为85.72 %。2) 患者服用钙磷调节药物的比例为68.32% (110/161),Morisky平均得分为1.11 ± 1.387分。3) 单因素方差分析显示:不同年龄组患者血钙水平存在统计学差异,不同透析龄组患者的血iPTH水平存在统计学差异,Morisky评分得分不同的患者的血钙水平也存在统计学差异,但是卡方分析显示:在不同年龄组、透析龄组以及Morisky评分组,血钙、血磷和血iPTH的达标率均无统计学差异。4) 方差分析显示:Morisky评分在男性和女性之间以及不同透析龄之间无差别,在不同年龄组间存在差异,其中年龄小于35岁的患者得分明显高于其他年龄组。5) 相关性分析结果显示:iPTH与尿酸、钙、矫正钙、钙磷乘积、白蛋白水平、透析龄之间成正相关,iPTH与磷水平之间成负相关(p < 0.05)。结论:根据KDIGO标准,我院该时期维持性透析患者的血钙达标率较高,而血磷和血iPTH水平未得到更好的控制;血钙水平与年龄和服药依从性相关,血iPTH水平与透析年限相关;年龄小的患者服药依次性低,而服药依从性高的患者血钙和血磷达标率高。临床需给予足够的重视,加强健康宣教。
Abstract: Objective: To investigate and analyze the calcium and phosphorus metabolism in patients with single-center maintenance hemodialysis and the use of calcium and phosphorus regulating drugs. Methods: Maintenance hemodialysis patients who received regular hemodialysis for more than 3 months in the blood purification center of Tongji Hospital Affiliated to Tongji University in January 2018 were selected as the research and analysis objects. The indicators of serum phosphorus, serum calcium, serum albumin and whole parathyroid hormone (iPTH) before dialysis were ret-rospectively analyzed. The standards of calcium, phosphorus and iPTH, the medication status of calcium and phosphorus regulating drugs were collected. Results: 1) The mean corrected blood calcium of the patients was (2.25 ± 0.19) mmol/L, and the corrected total calcium was lower than the target standard in 23 cases, accounting for 14.29%, 131 cases of bidders accounting for 81.37%, and 7 cases of patients higher than the standard value, accounting for 5.34%. The average blood phosphorus was (1.68 ± 0.51) mmol/L. The blood phosphorus index of 1 case was lower than the target standard, accounting for 0.61%. A total of 52 cases reached the standard, accounting for 32.29%. The average iPTH was (341.65 ± 351.81) pg/ml, and 1 case was lower than the target standard, accounting for 0.61%. A total of 22 cases reached the standard, accounting for 13.67%, and 138 cases were higher than the standard value, accounting for 85.72%. 2) The proportion of patients taking calcium and phosphorus regulating drugs was 68.32% (110/161), and the average score of Morisky was 1.11 ± 1.387. 3) The single factor analysis of variance showed that different age group patients’ blood calcium level statistical differences, different dialysis age group of patients with serum iPTH statistical differences, Morisky scale scores in patients with different blood calcium level are statistically significant, but a chi-square analysis showed: in different age groups, dialysis age group and Morisky group, blood calcium, phosphorus and blood iPTH success rate had no statistical difference. 4) Anova showed that there was no difference in Morisky score between male and female and between different dialysis ages. There was difference among different age groups. Patients younger than 35 years old scored significantly higher than other age groups. 5) Correlation analysis showed that there was a positive correlation between iPTH and calcium, urate, correction calcium, calcium phosphorus product, albumin level and a negative correlation between iPTH and phosphorus level. Conclusion: According to the KDIGO standard, the compliance rate of serum calcium of maintenance dialysis patients in our hospital was higher during this period, while the levels of serum phosphorus and blood iPTH were not better controlled. Blood calcium level was correlated with age and medication compliance, and blood iPTH level was correlated with dialysis age. Younger patients were less likely to take medication in turn, while patients with higher compliance had higher compliance rates of blood calcium and phosphorus. Enough attention should be paid to health education in clinic.
文章引用:余莹, 张晓琴, 张昆, 黄洁丽, 李江涛, 余晨. 单中心维持性血透患者钙磷代谢情况及用药依从性分析[J]. 临床医学进展, 2019, 9(9): 1113-1121. https://doi.org/10.12677/ACM.2019.99171

参考文献

[1] Slinin, Y., Foley, R.N. and Collins, A.J. (2005) Calcium, Phosphorus, Parathyroid Hormone, and Cardiovascular Dis-ease in Hemodialysis Patients: The USRDS Waves 1, 3, and 4 Study. Journal of the American Society of Nephrology, 16, 1788-1793. [Google Scholar] [CrossRef
[2] Morisky, D.E., Green, L.W. and Levine, D.M. (1986) Concurrent and Predictive Validity of a Self-Reported Measure of Medication Adherence. Medical Care, 24, 67-74. [Google Scholar] [CrossRef] [PubMed]
[3] 王莉, 李贵森, 刘志红. 慢性肾脏病矿物质和骨异常诊治指导[J]. 肾脏病与透析肾移植杂志, 2013, 22(6): 554-559.
[4] Floege, J., et al. (2011) Serum iPTH, Calcium and Phosphate, and the Risk of Mortality in a European Haemodialysis Population. Nephrology Dialysis Transplantation, 26, 1948-1955. [Google Scholar] [CrossRef] [PubMed]
[5] Tomiyama, C., et al. (2006) The Impact of Traditional and Non-Traditional Risk Factors on Coronary Calcification in Pre-Dialysis Patients. Nephrology Dialy-sis Transplantation, 21, 2464-2471. [Google Scholar] [CrossRef] [PubMed]
[6] Moe, S.M. and Block, G.A. (2009) KDIGO Clinical Practice Guideline forthe Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Dis-ease-Mineral and Bone Disorder. Kidney International, 76, 130.
[7] 唐莉, 欧阳凌霞, 姜继光, 施翎, 冯微微, 吕敏, 姚许平. 维持性血液透析患者钙磷代谢现状的单中心横断面研究[J]. 现代实用医学, 2016, 28(4): 3.
[8] 方春天, 席蔡, 刘张, 刘飞. 单中心维持性血液透析患者矿物质——骨异常的调查分析[J]. 中国中西医结合肾病杂志, 2018. 19(12): 3.
[9] 徐起, 吴美, 军叶, 萍郝, 丽程, 王光, 高顾, 雷霆, 闾志, 朱云, 柴冰. 单中心维持性血液透析患者的钙磷代谢调查[J]. 临床肾脏病杂志, 2015, 15(3): 6.
[10] Arenas, M.D., et al. (2006) Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: Changes of Clinical Practices and Their Effects on Outcomes and Quality Standards in Three Haemodialysis Units. Nephrology Dialysis Transplantation, 21, 1663-1668. [Google Scholar] [CrossRef] [PubMed]
[11] 孙鲁英, 王梅, 杨莉. 终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J]. 北京大学学报(医学版), 2005, 37(2): 3.
[12] Foley, R.N., Collins, A.J., Herzog, C.A., Ishani, A. and Kalra, P.A. (2009) Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults. Journal of the American Society of Nephrology, 20, 397-404. [Google Scholar] [CrossRef
[13] Isakova, T., et al. (2009) Phosphorus Binders and Survival on Hemodialysis. Journal of the American Society of Nephrology, 20, 388-396. [Google Scholar] [CrossRef
[14] Onufrak, S.J., et al. (2008) Phosphorus Levels Are Associated with Subclinical Atherosclerosis in the General Population. Atherosclerosis, 199, 424-431. [Google Scholar] [CrossRef] [PubMed]
[15] Ritter, C.S. and Slatopolsky, E. (2016) Phosphate Tox-icity in CKD: The Killer among Us. Clinical Journal of the American Society of Nephrology, 11, 1088-1100. [Google Scholar] [CrossRef
[16] Mohlenkamp, S., et al. (2007) Assessment of the Natural History of Coronary Artery Calcification and Identification of Its Determinants. Rationale of the 2nd Part of the Heinz Nixdorf Recall Study. Herz, 32, 108-120.
[17] Schlieper, G., et al. (2008) Vascular Access Calcification Predicts Mortality in Hemodialysis Patients. Kidney International, 74, 1582-1587. [Google Scholar] [CrossRef] [PubMed]